Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Health Literacy and Unmet Needs in Patients With Multiple Sclerosis: A Cross-Sectional Study.

Journal of clinical nursing·2026
Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.

Drugs - real world outcomes·2026
Same author

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Neurology·2026
Same author

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.

Neurology and therapy·2026

Related Experiment Video

Updated: May 8, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Big data in multiple sclerosis.

Maria Trojano1, Pietro Iaffaldano

  • 1Department of Translational Biomedicine and Neurosciences, University of Bari "Aldo Moro", Bari, Italy.

Current Opinion in Neurology
|April 2, 2026
PubMed
Summary
This summary is machine-generated.

Big data analytics in multiple sclerosis (MS) research are revolutionizing treatment strategies and disease understanding. Real-world evidence (RWE) from big data enhances personalized medicine and refines prognostic models for better patient outcomes.

Keywords:
artificial intelligencebig datamultiple sclerosisprognostic modelsreal-world evidence

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K

Related Experiment Videos

Last Updated: May 8, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K

Area of Science:

  • Neuroimmunology
  • Data Science in Medicine
  • Computational Biology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Understanding MS progression and optimizing treatment requires advanced analytical approaches.

Purpose of the Study:

  • To review key advancements in multiple sclerosis (MS) research driven by big data analytics.
  • To highlight the impact of real-world evidence (RWE) on MS treatment and prognosis.

Main Methods:

  • Systematic review of recent literature on big data applications in MS.
  • Analysis of diverse data sources including clinical records, MRI, genomics, and biomarkers.
  • Utilization of advanced analytical techniques and artificial intelligence (AI).

Main Results:

  • Real-world evidence (RWE) from MS big data has improved treatment strategies and personalized medicine.
  • Big data redefined disease progression, refined prognostic models, and informed treatment decisions during pregnancy.
  • Multimodal data frameworks enhance diagnostic performance and risk stratification in MS.
  • Progression independent of relapse activity is a key driver of disability.

Conclusions:

  • Big data approaches are transforming MS research and clinical practice.
  • RWE guides therapeutic decision-making and refines disease progression models.
  • Advanced analytics are crucial for developing precise prognostic tools in MS.